This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ontario Institute for Cancer Research. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Cindy Q Yao: Innovator in Breast Cancer Prognosis
Introduction
Cindy Q Yao is a prominent inventor based in North York, Canada. She has made significant contributions to the field of cancer research, particularly in the area of breast cancer prognosis. Her innovative work has the potential to improve treatment outcomes for patients undergoing endocrine therapy.
Latest Patents
Cindy Q Yao holds a patent titled "Gene signature of residual risk following endocrine treatment in early breast cancer." This patent describes a method for prognosing endocrine-only treatment in subjects with breast cancer. The method involves providing a tumor sample, determining the expression levels of at least 40 specific genes, comparing these levels to reference expression levels from control samples, and ultimately assessing the residual risk associated with breast cancer. This innovative approach aims to enhance the understanding of treatment efficacy and patient risk.
Career Highlights
Throughout her career, Cindy has worked with esteemed organizations, including the Ontario Institute for Cancer Research. Her research has focused on developing methodologies that can lead to better prognostic tools for breast cancer patients. Her dedication to advancing cancer research has positioned her as a key figure in the field.
Collaborations
Cindy has collaborated with notable colleagues such as Jane Bayani and John M S Bartlett. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.
Conclusion
Cindy Q Yao's contributions to breast cancer research through her innovative patent demonstrate her commitment to improving patient care. Her work exemplifies the importance of research in developing effective treatment strategies for cancer patients.